In this report, the study analysis was given on a worldwide scale, for instance, present and traditional PARKINSON'S DISEASE DRUGgrowth analysis, competitive analysis, and also the growth prospects of the central regions. The report gives an exhaustive investigation of this market at country & regional levels, and provides an analysis of the industry trends in each of the sub-segments, from sales, revenue and consumption. A quantitative and qualitative analysis of the main players in related regions is introduced, from the perspective of sales, revenue and price.
The global PARKINSON'S DISEASE DRUG market was valued at USD xxx million in 2019, and it is expected to reach a value of USD xxx million by 2026, at a CAGR of xx% over the forecast period 2021-2026. Correspondingly, the forecast analysis of PARKINSON'S DISEASE DRUG industry comprises of Asia, North America, South America, Middle East and Africa, Europe, with the sales and revenue data in each of the sub-segments.
At the upcoming section, this report discusses industrial policy, economic environment, in addition to the fabrication processes and cost structures of the industry. And this report encompasses the fundamental dynamics of the market which include drivers, opportunities, and challenges faced by the industry. Additionally, this report showed a keen market study of the main consumers, raw material manufacturers and distributors, etc.
Geographically, this report is segmented into several key Regions, with production, consumption, revenue (M USD), market share and growth rate of PARKINSON'S DISEASE DRUG in these regions, from 2014 to 2026 (forecast), covering
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- South America (Brazil, Argentina, Columbia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Global PARKINSON'S DISEASE DRUG market competition by top manufacturers, with production, price, revenue (value) and market share for each manufacturer; the top players including
- Merck
- Akorn
- GSK
- Novartis
- Boehringer Ingelheim
- Teva Pharmaceutical
- Abbvie
- Kyowa Hakko Kirin Pharma
- Astellas Pharma
- Desitin Arzneimittel
- Endo Pharmaceuticals
- F.Hoffmann-La Roche
- H.Lundbeck
- Valeant
- Apokyn
- Orion
- Stada Arzneimittel
- US WorldMeds
- Valeant Pharmaceuticals
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
- Sinemet-CR
- Trastal
- Madopar
- COMT Inhibitor
- Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, consumption (sales), market share and growth rate of PARKINSON'S DISEASE DRUG for each application, including
- Under 40 Years Old
- 40-65 Years Old
- Above 65 Years Old
If you have any special requirements, please let us know and we will offer you the report as you want.
Global PARKINSON'S DISEASE DRUG Assessment, With Major Companies Analysis,Regional Analysis, Breakdown Data by Application/Type
Table of Contents
Global PARKINSON'S DISEASE DRUG Market by Manufacturers, Regions, Type and Application, Forecast to 2026
1 Report Overview
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 PARKINSON'S DISEASE DRUG Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Assessment by Type
2.1 Sinemet-CR Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.2 Trastal Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.3 Madopar Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.4 COMT Inhibitor Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
2.5 Others Sales (K Units), Revenue (M USD) and Growth Rate 2014-2020
3 Asia Pacific PARKINSON'S DISEASE DRUG Market Assessment by Type
3.1 Asia Pacific Market Performance (Sales, Revenue)
3.2 Key Players in Asia Pacific
4 North America PARKINSON'S DISEASE DRUG Market Assessment by Type
4.1 North America Market Performance (Sales, Revenue)
4.2 Key Players in North America
5 Europe PARKINSON'S DISEASE DRUG Market Assessment by Type
4.1 Europe Market Performance (Sales, Revenue)
4.2 Key Players in Europe
6 South America PARKINSON'S DISEASE DRUG Market Assessment by Type
4.1 South America Market Performance (Sales, Revenue)
4.2 Key Players in South America
7 Middle Easr and Africa PARKINSON'S DISEASE DRUG Market Assessment by Type
4.1 Middle Easr and Africa Market Performance (Sales, Revenue)
4.2 Key Players in Middle Easr and Africa
8 World PARKINSON'S DISEASE DRUG Market Assessment by Type
8.1 Asia Pacific PARKINSON'S DISEASE DRUG Market Assessment by Application (Consumption and Market Share)
8.2 North America PARKINSON'S DISEASE DRUG Market Assessment by Application (Consumption and Market Share)
8.3 Europe PARKINSON'S DISEASE DRUG Market Assessment by Application (Consumption and Market Share)
8.4 South America PARKINSON'S DISEASE DRUG Market Assessment by Application (Consumption and Market Share)
8.5 Middle East and Africa PARKINSON'S DISEASE DRUG Market Assessment by Application (Consumption and Market Share)
9 Company Profiles/Analysis
9.1 Merck
9.1.1 Merck Profiles
9.1.2 Merck Product Portfolio
9.1.3 Merck PARKINSON'S DISEASE DRUG Business Performance
9.1.4 Merck PARKINSON'S DISEASE DRUG Business Development and Market Status
9.2 Akorn
9.2.1 Akorn Profiles
9.2.2 Akorn Product Portfolio
9.2.3 Akorn PARKINSON'S DISEASE DRUG Business Performance
9.2.4 Akorn PARKINSON'S DISEASE DRUG Business Development and Market Status
9.3 GSK
9.3.1 GSK Profiles
9.3.2 GSK Product Portfolio
9.3.3 GSK PARKINSON'S DISEASE DRUG Business Performance
9.3.4 GSK PARKINSON'S DISEASE DRUG Business Development and Market Status
9.4 Novartis
9.4.1 Novartis Profiles
9.4.2 Novartis Product Portfolio
9.4.3 Novartis PARKINSON'S DISEASE DRUG Business Performance
9.4.4 Novartis PARKINSON'S DISEASE DRUG Business Development and Market Status
9.5 Boehringer Ingelheim
9.5.1 Boehringer Ingelheim Profiles
9.5.2 Boehringer Ingelheim Product Portfolio
9.5.3 Boehringer Ingelheim PARKINSON'S DISEASE DRUG Business Performance
9.5.4 Boehringer Ingelheim PARKINSON'S DISEASE DRUG Business Development and Market Status
9.6 Teva Pharmaceutical
9.6.1 Teva Pharmaceutical Profiles
9.6.2 Teva Pharmaceutical Product Portfolio
9.6.3 Teva Pharmaceutical PARKINSON'S DISEASE DRUG Business Performance
9.6.4 Teva Pharmaceutical PARKINSON'S DISEASE DRUG Business Development and Market Status
9.7 Abbvie
9.7.1 Abbvie Profiles
9.7.2 Abbvie Product Portfolio
9.7.3 Abbvie PARKINSON'S DISEASE DRUG Business Performance
9.7.4 Abbvie PARKINSON'S DISEASE DRUG Business Development and Market Status
9.8 Kyowa Hakko Kirin Pharma
9.8.1 Kyowa Hakko Kirin Pharma Profiles
9.8.2 Kyowa Hakko Kirin Pharma Product Portfolio
9.8.3 Kyowa Hakko Kirin Pharma PARKINSON'S DISEASE DRUG Business Performance
9.8.4 Kyowa Hakko Kirin Pharma PARKINSON'S DISEASE DRUG Business Development and Market Status
9.9 Astellas Pharma
9.9.1 Astellas Pharma Profiles
9.9.2 Astellas Pharma Product Portfolio
9.9.3 Astellas Pharma PARKINSON'S DISEASE DRUG Business Performance
9.9.4 Astellas Pharma PARKINSON'S DISEASE DRUG Business Development and Market Status
9.10 Desitin Arzneimittel
9.10.1 Desitin Arzneimittel Profiles
9.10.2 Desitin Arzneimittel Product Portfolio
9.10.3 Desitin Arzneimittel PARKINSON'S DISEASE DRUG Business Performance
9.10.4 Desitin Arzneimittel PARKINSON'S DISEASE DRUG Business Development and Market Status
9.11 Endo Pharmaceuticals
9.12 F.Hoffmann-La Roche
9.13 H.Lundbeck
9.14 Valeant
9.15 Apokyn
9.16 Orion
9.17 Stada Arzneimittel
9.18 US WorldMeds
9.19 Valeant Pharmaceuticals
10 World PARKINSON'S DISEASE DRUG Market Assessment by Players
10.1 Global PARKINSON'S DISEASE DRUG Sales (K Units) and Market Share by Players 2014-2020
10.2 Global PARKINSON'S DISEASE DRUG Revenue (M USD) and Market Share by Players 2014-2020
10.3 Global PARKINSON'S DISEASE DRUG Price (USD/Unit) of Players 2014-2020
10.4 Global PARKINSON'S DISEASE DRUG Gross Margin of Players 2014-2020
10.5 Market Concentration
11 Regional Market Performance by Segment of Players
11.1 North America
11.1.1 North America PARKINSON'S DISEASE DRUG Sales Assessment of Players 2014-2020
11.1.2 North America PARKINSON'S DISEASE DRUG Revenue Assessment of Players 2014-2020
11.1.3 North America PARKINSON'S DISEASE DRUG Price Assessment of Players 2014-2020
11.1.4 North America PARKINSON'S DISEASE DRUG Gross Margin Assessment of Players 2014-2020
11.1.5 Market Concentration
11.2 Europe
11.2.1 Europe PARKINSON'S DISEASE DRUG Sales Assessment of Players 2014-2020
11.2.2 Europe PARKINSON'S DISEASE DRUG Revenue Assessment of Players of Manufacturers 2014-2020
11.2.3 Europe PARKINSON'S DISEASE DRUG Price Assessment of Players 2014-2020
11.2.4 Europe PARKINSON'S DISEASE DRUG Gross Margin Assessment of Players 2014-2020
11.2.5 Market Concentration
11.3 Asia-Pacific Market Performance for Manufacturers
11.3.1 Asia-Pacific PARKINSON'S DISEASE DRUG Sales Assessment of Players 2014-2020
11.3.2 Asia-Pacific PARKINSON'S DISEASE DRUG Revenue Assessment of Players 2014-2020
11.3.3 Asia-Pacific PARKINSON'S DISEASE DRUG Price Assessment of Players 2014-2020
11.3.4 Asia-Pacific PARKINSON'S DISEASE DRUG Gross Margin Assessment of Players 2014-2020
11.3.5 Market Concentration
11.4 South America Market Performance for Players
11.4.1 South America PARKINSON'S DISEASE DRUG Sales Assessment of Players 2014-2020
11.4.2 South America PARKINSON'S DISEASE DRUG Revenue Assessment of Players 2014-2020
11.4.3 South America PARKINSON'S DISEASE DRUG Price Assessment of Players 2014-2020
11.4.4 South America PARKINSON'S DISEASE DRUG Gross Margin Assessment of Players 2014-2020
11.4.5 Market Concentration
11.5 Middle East and Africa Market Performance for Players
11.5.1 Middle East and Africa PARKINSON'S DISEASE DRUG Sales Assessment of Players 2014-2020
11.5.2 Middle East and Africa PARKINSON'S DISEASE DRUG Revenue Assessment of Players 2014-2020
11.5.3 Middle East and Africa PARKINSON'S DISEASE DRUG Price Assessment of Players 2014-2020
11.5.4 Middle East and Africa PARKINSON'S DISEASE DRUG Gross Margin Assessment of Players 2014-2020
11.5.5 Market Concentration
12 Regional Market Performance by Segment of Countries
12.1 Asia Pacific
12.1.1 Asia Pacific PARKINSON'S DISEASE DRUG Sales by Countries/Regions 2014-2020
12.1.2 Asia Pacific PARKINSON'S DISEASE DRUG Revenue by Countries/Regions 2014-2020
12.1.3 Asia Pacific PARKINSON'S DISEASE DRUG Average Price by Countries/Regions 2014-2020
12.2 North America
12.2.1 North America PARKINSON'S DISEASE DRUG Sales by Countries/Regions 2014-2020
12.2.2 North America PARKINSON'S DISEASE DRUG Revenue by Countries/Regions 2014-2020
12.2.3 North America PARKINSON'S DISEASE DRUG Average Price by Countries/Regions 2014-2020
12.3 Europe
12.3.1 Europe PARKINSON'S DISEASE DRUG Sales by Countries/Regions 2014-2020
12.3.2 Europe PARKINSON'S DISEASE DRUG Revenue by Countries/Regions 2014-2020
12.3.3 Europe PARKINSON'S DISEASE DRUG Average Price by Countries/Regions 2014-2020
12.4 South America
12.4.1 South America PARKINSON'S DISEASE DRUG Sales by Countries/Regions 2014-2020
12.4.2 South America PARKINSON'S DISEASE DRUG Revenue by Countries/Regions 2014-2020
12.4.3 South America PARKINSON'S DISEASE DRUG Average Price by Countries/Regions 2014-2020
12.5 Middle East and Africa
12.5.1 Middle East and Africa PARKINSON'S DISEASE DRUG Sales by Countries/Regions 2014-2020
12.5.2 Middle East and Africa PARKINSON'S DISEASE DRUG Revenue by Countries/Regions 2014-2020
12.5.3 Middle East and Africa PARKINSON'S DISEASE DRUG Average Price by Countries/Regions 2014-2020
13 Technology and Opportunity
13.1 Technology
13.2 Market Opportunity
14 World PARKINSON'S DISEASE DRUG Sales & Revenue Forecast 2021-2026
14.1 World PARKINSON'S DISEASE DRUG Sales and Revenue Forecast by Regions 2021-2026
14.1.1 World PARKINSON'S DISEASE DRUGSales and Market Share by Regions
14.1.2 World PARKINSON'S DISEASE DRUGRevenue and Market Share by Regions
15 Asia PARKINSON'S DISEASE DRUG Market Forecast 2021-2026
15.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
15.1.1 Sinemet-CR
15.1.2 Trastal
15.1.3 Madopar
15.1.4 COMT Inhibitor
15.1.5 Others
15.2 Consumption Forecast by Application, 2021-2026
16 North America PARKINSON'S DISEASE DRUG Market Forecast 2021-2026
16.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
16.1.1 Sinemet-CR
16.1.2 Trastal
16.1.3 Madopar
16.1.4 COMT Inhibitor
16.1.5 Others
16.2 Consumption Forecast by Application, 2021-2026
17 Europe PARKINSON'S DISEASE DRUG Market Forecast 2021-2026
17.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
17.1.1 Sinemet-CR
17.1.2 Trastal
17.1.3 Madopar
17.1.4 COMT Inhibitor
17.1.5 Others
17.2 Consumption Forecast by Application, 2021-2026
18 South America PARKINSON'S DISEASE DRUG Market Forecast 2021-2026
18.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
18.1.1 Sinemet-CR
18.1.2 Trastal
18.1.3 Madopar
18.1.4 COMT Inhibitor
18.1.5 Others
18.2 Consumption Forecast by Application, 2021-2026
19 Middle East and Africa PARKINSON'S DISEASE DRUG Market Forecast 2021-2026
19.1 Sales and Revenue (M USD) Forecast by Type, 2021-2026
19.1.1 Sinemet-CR
19.1.2 Trastal
19.1.3 Madopar
19.1.4 COMT Inhibitor
19.1.5 Others
19.2 Consumption Forecast by Application, 2021-2026
20 Price (USD/Unit) and Gross Profit Forecast
20.1 Global PARKINSON'S DISEASE DRUG Price (USD/Unit) Trend 2021-2026
20.2 Global PARKINSON'S DISEASE DRUG Gross Profit Trend 2021-2026
21 Conclusion
List of Tables and Figures
Figure Product Picture of PARKINSON'S DISEASE DRUG
Table Players List in the Report
Table Mergers & Acquisitions, Expansion Plans
Table Global PARKINSON'S DISEASE DRUG Market Size (Volume) and Growth Rate by Type (2019-2026)
Global PARKINSON'S DISEASE DRUG Market Share by Application (2019-2026)
Figure Industry Chain Structure of PARKINSON'S DISEASE DRUG
Table Product Application and Standard
Table Key Suppliers of Raw Material/Components
Figure Industry Chain Structure of PARKINSON'S DISEASE DRUG
Table Representative Downstream Enterprises of PARKINSON'S DISEASE DRUG
Figure New Project SWOT Analysis of PARKINSON'S DISEASE DRUG
Table Industry Policy List of PARKINSON'S DISEASE DRUG 2019
Table World PARKINSON'S DISEASE DRUG Sales (Unit) by Type (2014-2020)
Figure World PARKINSON'S DISEASE DRUG Sales Market Share (%) by Type 2014-2020
Table World 2014-2020 PARKINSON'S DISEASE DRUG Revenue (M USD) by Type
Figure World PARKINSON'S DISEASE DRUG Revenue Market Share (%) by Type 2014-2020
Table Sinemet-CR-Sales (K Units), Revenue and Growth Rate
Table Trastal-Sales (K Units), Revenue and Growth Rate
Table Madopar-Sales (K Units), Revenue and Growth Rate
Table COMT Inhibitor-Sales (K Units), Revenue and Growth Rate
Table Others-Sales (K Units), Revenue and Growth Rate
Table World Madopar Revenue (M USD) and Growth Rate
Table Asia Pacific PARKINSON'S DISEASE DRUG Sales by Type (2014-2020)
Figure Asia Pacific PARKINSON'S DISEASE DRUG Sales Market Share by Type (2014-2020)
Table Asia Pacific PARKINSON'S DISEASE DRUG Revenue by Type (2014-2020)
Figure Asia Pacific PARKINSON'S DISEASE DRUG Revenue Market Share by Type (2014-2020)
Table Key Players in Asia Pacific
Table North America PARKINSON'S DISEASE DRUG Sales by Type (2014-2020)
Figure North America PARKINSON'S DISEASE DRUG Sales Market Share by Type (2014-2020)
Table North America PARKINSON'S DISEASE DRUG Revenue by Type (2014-2020)
Figure North America PARKINSON'S DISEASE DRUG Revenue Market Share by Type (2014-2020)
Table Key Players in North America
Table Europe PARKINSON'S DISEASE DRUG Sales by Type (2014-2020)
Figure Europe PARKINSON'S DISEASE DRUG Sales Market Share by Type (2014-2020)
Table Europe PARKINSON'S DISEASE DRUG Revenue by Type (2014-2020)
Figure Europe PARKINSON'S DISEASE DRUG Revenue Market Share by Type (2014-2020)
Table Key Players in Europe
Table South America PARKINSON'S DISEASE DRUG Sales by Type (2014-2020)
Figure South America PARKINSON'S DISEASE DRUG Sales Market Share by Type (2014-2020)
Table South America PARKINSON'S DISEASE DRUG Revenue by Type (2014-2020)
Figure South America PARKINSON'S DISEASE DRUG Revenue Market Share by Type (2014-2020)
Table Key Players in South America
Table Middle East and Africa PARKINSON'S DISEASE DRUG Sales by Type (2014-2020)
Figure Middle East and Africa PARKINSON'S DISEASE DRUG Sales Market Share by Type (2014-2020)
Table Middle East and Africa PARKINSON'S DISEASE DRUG Revenue by Type (2014-2020)
Figure Middle East and Africa PARKINSON'S DISEASE DRUG Revenue Market Share by Type (2014-2020)
Table Key Players in Middle East and Africa
Table World PARKINSON'S DISEASE DRUG Consumption by Application (2014-2020)
Table World PARKINSON'S DISEASE DRUG Consumption Market Share by Application (2014-2020)
Table Asia PARKINSON'S DISEASE DRUG Consumption by Application (2014-2020)
Table Asia PARKINSON'S DISEASE DRUG Consumption Market Share by Application (2014-2020)
Table North America PARKINSON'S DISEASE DRUG Consumption by Application (2014-2020)
Table North America PARKINSON'S DISEASE DRUG Consumption Market Share by Application (2014-2020)
Table Europe PARKINSON'S DISEASE DRUG Consumption by Application (2014-2020)
Table Europe PARKINSON'S DISEASE DRUG Consumption Market Share by Application (2014-2020)
Table South America PARKINSON'S DISEASE DRUG Consumption by Application (2014-2020)
Table South America PARKINSON'S DISEASE DRUG Consumption Market Share by Application (2014-2020)
Table Middle East and Africa PARKINSON'S DISEASE DRUG Consumption by Application (2014-2020)
Table Middle East and Africa PARKINSON'S DISEASE DRUG Consumption Market Share by Application (2014-2020)
Table Merck Profiles
Table Merck Product Information
Table Merck PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Merck PARKINSON'S DISEASE DRUG Sales Market Share 2014-2020
Table Merck PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Akorn Profiles
Table Akorn Product Information
Table Akorn PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Akorn PARKINSON'S DISEASE DRUG Sales Market Share 2014-2020
Table Akorn PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table GSK Profiles
Table GSK Product Information
Table GSK PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table GSK PARKINSON'S DISEASE DRUG Sales Market Share 2014-2020
Table GSK PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Novartis Profiles
Table Novartis Product Information
Table Novartis PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Novartis PARKINSON'S DISEASE DRUG Sales Market Share 2014-2020
Table Novartis PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Boehringer Ingelheim Profiles
Table Boehringer Ingelheim Product Information
Table Boehringer Ingelheim PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Boehringer Ingelheim PARKINSON'S DISEASE DRUG Sales Market Share 2014-2020
Table Boehringer Ingelheim PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Teva Pharmaceutical Profiles
Table Teva Pharmaceutical Product Information
Table Teva Pharmaceutical PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Teva Pharmaceutical PARKINSON'S DISEASE DRUG Sales Market Share 2014-2020
Table Teva Pharmaceutical PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Abbvie Profiles
Table Abbvie Product Information
Table Abbvie PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Abbvie PARKINSON'S DISEASE DRUG Sales Market Share 2014-2020
Table Abbvie PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Kyowa Hakko Kirin Pharma Profiles
Table Kyowa Hakko Kirin Pharma Product Information
Table Kyowa Hakko Kirin Pharma PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Kyowa Hakko Kirin Pharma PARKINSON'S DISEASE DRUG Sales Market Share 2014-2020
Table Kyowa Hakko Kirin Pharma PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Astellas Pharma Profiles
Table Astellas Pharma Product Information
Table Astellas Pharma PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Astellas Pharma PARKINSON'S DISEASE DRUG Sales Middle East and Africa 2014-2020
Table Astellas Pharma PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Desitin Arzneimittel Profiles
Table Desitin Arzneimittel Product Information
Table Desitin Arzneimittel PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Desitin Arzneimittel PARKINSON'S DISEASE DRUG Sales Middle East and Africa 2014-2020
Table Desitin Arzneimittel PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Endo Pharmaceuticals Profiles
Table Endo Pharmaceuticals Product Information
Table Endo Pharmaceuticals PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Endo Pharmaceuticals PARKINSON'S DISEASE DRUG Sales Middle East and Africa 2014-2020
Table Endo Pharmaceuticals PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table F.Hoffmann-La Roche Profiles
Table F.Hoffmann-La Roche Product Information
Table F.Hoffmann-La Roche PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table F.Hoffmann-La Roche PARKINSON'S DISEASE DRUG Sales Middle East and Africa 2014-2020
Table F.Hoffmann-La Roche PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table H.Lundbeck Profiles
Table H.Lundbeck Product Information
Table H.Lundbeck PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table H.Lundbeck PARKINSON'S DISEASE DRUG Sales Middle East and Africa 2014-2020
Table H.Lundbeck PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Valeant Profiles
Table Valeant Product Information
Table Valeant PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Valeant PARKINSON'S DISEASE DRUG Sales Middle East and Africa 2014-2020
Table Valeant PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Apokyn Profiles
Table Apokyn Product Information
Table Apokyn PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Apokyn PARKINSON'S DISEASE DRUG Sales Middle East and Africa 2014-2020
Table Apokyn PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Orion Profiles
Table Orion Product Information
Table Orion PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Orion PARKINSON'S DISEASE DRUG Sales Middle East and Africa 2014-2020
Table Orion PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Stada Arzneimittel Profiles
Table Stada Arzneimittel Product Information
Table Stada Arzneimittel PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Stada Arzneimittel PARKINSON'S DISEASE DRUG Sales Middle East and Africa 2014-2020
Table Stada Arzneimittel PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table US WorldMeds Profiles
Table US WorldMeds Product Information
Table US WorldMeds PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table US WorldMeds PARKINSON'S DISEASE DRUG Sales Middle East and Africa 2014-2020
Table US WorldMeds PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Valeant Pharmaceuticals Profiles
Table Valeant Pharmaceuticals Product Information
Table Valeant Pharmaceuticals PARKINSON'S DISEASE DRUG Sales (K Units), Revenue (M USD), Price (USD/Unit), Cost (USD/Unit) and Gross Profit 2014-2020
Table Valeant Pharmaceuticals PARKINSON'S DISEASE DRUG Sales Middle East and Africa 2014-2020
Table Valeant Pharmaceuticals PARKINSON'S DISEASE DRUG Market Status Change 2014-2020
Table Sales (Unit) of Players (2014-2020)
Table Sales Share of Players (2014-2020)
Figure World PARKINSON'S DISEASE DRUG Sales Share in 2019
Table Revenue of Players (2014-2020)
Table Revenue Share of Players (2014-2020)
Figure World PARKINSON'S DISEASE DRUG Revenue Share in 2019
Table Average Price of Players (2014-2020)
Figure Average Price of Players (2014-2020)
Table Gross Margin of Players (2014-2020)
Figure Gross Margin of Players in 2014
Figure Gross Margin of Players in 2019
Figure World Market Concentration (2014-2019)
Table Top 5 Players Sales Share (2014-2019)
Table Asia Pacific PARKINSON'S DISEASE DRUG Sales (Unit) of Players (2014-2019)
Table Asia Pacific PARKINSON'S DISEASE DRUG Sales Share of Players (2014-2019)
Figure Asia Pacific PARKINSON'S DISEASE DRUG Sales Share in 2019
Table Asia Pacific PARKINSON'S DISEASE DRUG Revenue of Players (2014-2019)
Table Asia Pacific PARKINSON'S DISEASE DRUG Revenue Share of Players (2014-2019)
Figure Asia Pacific PARKINSON'S DISEASE DRUG Revenue Share in 2019
Table Asia Pacific PARKINSON'S DISEASE DRUG Price of Players (2014-2019)
Table Asia Pacific PARKINSON'S DISEASE DRUG Gross Margin of Players (2014-2019)
Figure Asia Pacific PARKINSON'S DISEASE DRUG Gross Margin Share in 2019
Figure Asia Pacific Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table North America PARKINSON'S DISEASE DRUG Sales (Unit) of Players (2014-2019)
Table North America PARKINSON'S DISEASE DRUG Sales Share of Players (2014-2019)
Figure North America PARKINSON'S DISEASE DRUG Sales Share in 2019
Table North America PARKINSON'S DISEASE DRUG Revenue of Players (2014-2019)
Table North America PARKINSON'S DISEASE DRUG Revenue Share of Players (2014-2019)
Figure North America PARKINSON'S DISEASE DRUG Revenue Share in 2019
Table North America PARKINSON'S DISEASE DRUG Price of Players (2014-2019)
Table North America PARKINSON'S DISEASE DRUG Gross Margin of Players (2014-2019)
Figure North America PARKINSON'S DISEASE DRUG Gross Margin Share in 2019
Figure North America Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Europe PARKINSON'S DISEASE DRUG Sales (Unit) of Players (2014-2019)
Table Europe PARKINSON'S DISEASE DRUG Sales Share of Players (2014-2019)
Figure Europe PARKINSON'S DISEASE DRUG Sales Share in 2019
Table Europe PARKINSON'S DISEASE DRUG Revenue of Players (2014-2019)
Table Europe PARKINSON'S DISEASE DRUG Revenue Share of Players (2014-2019)
Figure Europe PARKINSON'S DISEASE DRUG Revenue Share in 2019
Table Europe PARKINSON'S DISEASE DRUG Price of Players (2014-2019)
Table Europe PARKINSON'S DISEASE DRUG Gross Margin of Players (2014-2019)
Figure Europe PARKINSON'S DISEASE DRUG Gross Margin Share in 2019
Figure Europe Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table South America PARKINSON'S DISEASE DRUG Sales (Unit) of Players (2014-2019)
Table South America PARKINSON'S DISEASE DRUG Sales Share of Players (2014-2019)
Figure South America PARKINSON'S DISEASE DRUG Sales Share in 2019
Table South America PARKINSON'S DISEASE DRUG Revenue of Players (2014-2019)
Table South America PARKINSON'S DISEASE DRUG Revenue Share of Players (2014-2019)
Figure South America PARKINSON'S DISEASE DRUG Revenue Share in 2019
Table South America PARKINSON'S DISEASE DRUG Price of Players (2014-2019)
Table South America PARKINSON'S DISEASE DRUG Gross Margin of Players (2014-2019)
Figure South America PARKINSON'S DISEASE DRUG Gross Margin Share in 2019
Figure South America Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Middle East and Africa PARKINSON'S DISEASE DRUG Sales (Unit) of Players (2014-2019)
Table Middle East and Africa PARKINSON'S DISEASE DRUG Sales Share of Players (2014-2019)
Figure Middle East and Africa PARKINSON'S DISEASE DRUG Sales Share in 2019
Table Middle East and Africa PARKINSON'S DISEASE DRUG Revenue of Players (2014-2019)
Table Middle East and Africa PARKINSON'S DISEASE DRUG Revenue Share of Players (2014-2019)
Figure Middle East and Africa PARKINSON'S DISEASE DRUG Revenue Share in 2019
Table Middle East and Africa PARKINSON'S DISEASE DRUG Price of Players (2014-2019)
Table Middle East and Africa PARKINSON'S DISEASE DRUG Gross Margin of Players (2014-2019)
Figure Middle East and Africa PARKINSON'S DISEASE DRUG Gross Margin Share in 2019
Figure Middle East and Africa Market Concentration (2014-2019)
Table Top 5 Sales Share (2014-2019)
Table Asia Pacific PARKINSON'S DISEASE DRUG Sales by Countries/Region (2014-2020)
Figure Asia Pacific PARKINSON'S DISEASE DRUG Sales and Growth Rate (2014-2020)
Table Asia Pacific PARKINSON'S DISEASE DRUG Sales Share by Countries/Region (2014-2020)
Figure Asia Pacific PARKINSON'S DISEASE DRUG Sales Share by Countries/Region in 2019
Table Asia Pacific PARKINSON'S DISEASE DRUG Revenue (Million USD) by Countries (2014-2020)
Figure Asia Pacific PARKINSON'S DISEASE DRUG Revenue and Growth Rate (2014-2020)
Table Asia Pacific PARKINSON'S DISEASE DRUG Revenue Share by Countries/Region (2014-2020)
Figure Asia Pacific PARKINSON'S DISEASE DRUG Revenue Share by Countries/Region in 2019
Table Asia Pacific PARKINSON'S DISEASE DRUG Average Price (USD/Unit) by Countries (2014-2020)
Table North America PARKINSON'S DISEASE DRUG Sales by Countries/Region (2014-2020)
Figure North America PARKINSON'S DISEASE DRUG Sales and Growth Rate (2014-2020)
Table North America PARKINSON'S DISEASE DRUG Sales Share by Countries/Region (2014-2020)
Figure North America PARKINSON'S DISEASE DRUG Sales Share by Countries/Region in 2019
Table North America PARKINSON'S DISEASE DRUG Revenue (Million USD) by Countries (2014-2020)
Figure North America PARKINSON'S DISEASE DRUG Revenue and Growth Rate (2014-2020)
Table North America PARKINSON'S DISEASE DRUG Revenue Share by Countries/Region (2014-2020)
Figure North America PARKINSON'S DISEASE DRUG Revenue Share by Countries/Region in 2019
Table North America PARKINSON'S DISEASE DRUG Average Price (USD/Unit) by Countries (2014-2020)
Table Europe PARKINSON'S DISEASE DRUG Sales by Countries/Region (2014-2020)
Figure Europe PARKINSON'S DISEASE DRUG Sales and Growth Rate (2014-2020)
Table Europe PARKINSON'S DISEASE DRUG Sales Share by Countries/Region (2014-2020)
Figure Europe PARKINSON'S DISEASE DRUG Sales Share by Countries/Region in 2019
Table Europe PARKINSON'S DISEASE DRUG Revenue (Million USD) by Countries (2014-2020)
Figure Europe PARKINSON'S DISEASE DRUG Revenue and Growth Rate (2014-2020)
Table Europe PARKINSON'S DISEASE DRUG Revenue Share by Countries/Region (2014-2020)
Figure Europe PARKINSON'S DISEASE DRUG Revenue Share by Countries/Region in 2019
Table Europe PARKINSON'S DISEASE DRUG Average Price (USD/Unit) by Countries (2014-2020)
Table South America PARKINSON'S DISEASE DRUG Sales by Countries/Region (2014-2020)
Figure South America PARKINSON'S DISEASE DRUG Sales and Growth Rate (2014-2020)
Table South America PARKINSON'S DISEASE DRUG Sales Share by Countries/Region (2014-2020)
Figure South America PARKINSON'S DISEASE DRUG Sales Share by Countries/Region in 2019
Table South America PARKINSON'S DISEASE DRUG Revenue (Million USD) by Countries (2014-2020)
Figure South America PARKINSON'S DISEASE DRUG Revenue and Growth Rate (2014-2020)
Table South America PARKINSON'S DISEASE DRUG Revenue Share by Countries/Region (2014-2020)
Figure South America PARKINSON'S DISEASE DRUG Revenue Share by Countries/Region in 2019
Table South America PARKINSON'S DISEASE DRUG Average Price (USD/Unit) by Countries (2014-2020)
Table Middle East and Africa PARKINSON'S DISEASE DRUG Sales by Countries/Region (2014-2020)
Figure Middle East and Africa PARKINSON'S DISEASE DRUG Sales and Growth Rate (2014-2020)
Table Middle East and Africa PARKINSON'S DISEASE DRUG Sales Share by Countries/Region (2014-2020)
Figure Middle East and Africa PARKINSON'S DISEASE DRUG Sales Share by Countries/Region in 2019
Table Middle East and Africa PARKINSON'S DISEASE DRUG Revenue (Million USD) by Countries (2014-2020)
Figure Middle East and Africa PARKINSON'S DISEASE DRUG Revenue and Growth Rate (2014-2020)
Table Middle East and Africa PARKINSON'S DISEASE DRUG Revenue Share by Countries/Region (2014-2020)
Figure Middle East and Africa PARKINSON'S DISEASE DRUG Revenue Share by Countries/Region in 2019
Table Middle East and Africa PARKINSON'S DISEASE DRUG Average Price (USD/Unit) by Countries (2014-2020)
Table Key Opportunities and Drivers
Table World PARKINSON'S DISEASE DRUG Sales (Unit) by Regions (2020-2025)
Figure World PARKINSON'S DISEASE DRUG Sales (Unit) and Growth Rate (2020-2025)
Table World PARKINSON'S DISEASE DRUG Sales Share by Regions (2020-2025)
Figure World PARKINSON'S DISEASE DRUG Sales Share by Regions in 2025
Table World PARKINSON'S DISEASE DRUG Revenue by Regions (2020-2025)
Figure World PARKINSON'S DISEASE DRUG Revenue and Growth Rate (2020-2025)
Table World PARKINSON'S DISEASE DRUG Revenue Share by Regions (2020-2025)
Figure World PARKINSON'S DISEASE DRUG Revenue Share by Regions in 2025
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Figure Sales (Unit) and Growth Rate (2020-2025)
Figure Revenue (Million USD) and Growth Rate (2020-2025)
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Figure Sales (Unit) and Growth Rate (2020-2025)
Figure Revenue (Million USD) and Growth Rate (2020-2025)
Table Sales (Unit) & Revenue (Million USD), 2020-2025
Table Consumption (K Units) Forecast by Application (2020-2025)
Figure Consumption (K Units) Forecast by Application (2020-2025)
Global Parkinson's Disease Therapeutics Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 99
Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of The central nervous system that affects both The motor system and non-motor systems. The symptoms usually emerge slowly, and as The disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced st......
Global Amantadine Hydrochloride Market Insights, Forecast to 2029
Published: 29-Aug-2023 Price: US 4900 Onwards Pages: 109
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
The global Amantadine Hydrochloride market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
Amantadine hydrochloride is clinically effective in preventing and treating infections of various influenza A viruses. In the influenza epidemic period, this product is use......
Global Rasagiline Tablet Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 107
Rasagiline (Azilect, Azipron) is an irreversible inhibitor of monoamine oxidase-B used as a monotherapy to treat symptoms in early Parkinson's disease or as an adjunct therapy in more advanced cases.
The global Rasagiline Tablet market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The racemic form of the drug was invented by Aspro Nicholas in the early 1970s. Moussa B.H. Youdim identifi......
Global Parkinsons Disease Drug Market Insights, Forecast to 2029
Published: 02-Aug-2023 Price: US 4900 Onwards Pages: 113
Most people with Parkinson's disease eventually need a medication called levodopa. Levodopa is absorbed by the nerve cells in your brain and turned into the chemical dopamine, which is used to transmit messages between the parts of the brain and nerves that control movement.
The global Parkinsons Disease Drug market is projected to grow from US$ 5763.6 million in 2023 to US$ 7419.9 million by 2029, at a Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period.
Global P......
Global Rasagiline Tablet Market Research Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 2680 Onwards Pages: 137
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Rasagiline Tablet Professional Survey Report 2023, Forecast to 2028
Published: 20-Mar-2023 Price: US 3280 Onwards Pages: 109
Rasagiline is used alone or with other medications (such as levodopa/carbidopa) to treat symptoms of Parkinson's disease. It can help improve symptoms such as shakiness, stiffness, and difficulty moving. It can also help reduce the amount of "off" time (periods of slow movement or stiffness).
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data fo......
Global Amantadine Hydrochloride Market Research Report 2023
Published: 09-Mar-2023 Price: US 2900 Onwards Pages: 98
Amantadine hydrochloride (CAS 665-66-7), C10H18ClN, the formula weight is 187.71, and its form is white crystal powder.
Highlights
The global Amantadine Hydrochloride market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
Amantadine hydrochloride is clinically effective......
Global Parkinson's Disease (PD) Drugs Professional Survey Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 3280 Onwards Pages: 133
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
Global Parkinson's Disease (PD) Drugs Market Research Report 2023, Forecast to 2028
Published: 21-Feb-2023 Price: US 2680 Onwards Pages: 159
Levodopa, the most effective Parkinson's disease medication, is a natural chemical that passes into your brain and is converted to dopamine. Levodopa is combined with carbidopa (Lodosyn), which protects levodopa from early conversion to dopamine outside your brain. This prevents or lessens side effects such as nausea.
Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market v......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
